SciRhom
PrivateLast Round
Series A
Jul 9, 2024
Total Funding Raised
$105.28M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
SciRhom is a biotechnology company that develops first-in-class therapeutic antibodies targeting iRhom2 to treat autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SciRhom Comparables
Compare SciRhom with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Johnson & Johnson | 69% | |
| AstraZeneca | 66% | |
| Shattuck Labs | 63% | |
SciRhom Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 9, 2024 | ||||
| Seed | Nov 30, 2021 | ||||
| Seed | Jan 12, 2021 | ||||
| Seed | Nov 5, 2019 |
Key People
Founding team and executive leadership
SciRhom Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MIG Capital | Series A |
| Andera Partners | Series A |
| MIG AG | Series A |
| Ventura Ace | Seed |
| Hadean Ventures | Series A |
| Wellington Partners | Series A |
| Bayern Kapital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 828% MoM, from 67 to 622.
- Apr 4, 2026
Monthly visitors grew 92% MoM.
SciRhom Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SciRhom's valuation, stock price, and market status.